CanSino Biologics Inc. Stock OTC Markets
Stocks
CASBF
CNE100003F01
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
10:56:23 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 2.950 USD | -35.87% |
|
-.--% | -37.83% |
| 08-27 | CanSino Biologics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-26 | CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines | MT |
| Market Cap | 15.88B 2.37B 2.09B 1.98B 1.78B 3.36B 227B 3.41B 23.64B 9.1B 116B 8.89B 8.7B 372B | P/E 2026 * |
71.6x | P/E 2027 * | 24x |
|---|---|---|---|---|---|
| Enterprise Value | 15.91B 2.37B 2.09B 1.98B 1.79B 3.37B 227B 3.41B 23.67B 9.11B 116B 8.9B 8.71B 373B | EV / Sales 2026 * |
11x | EV / Sales 2027 * | 8.99x |
| Free-Float |
39.3% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 6185 | Delayed | |
Deutsche Boerse AG
| CJH | Delayed | |
|
OTC Markets
| CASBF | Delayed | |
|
Tradegate
| CJH | Real-time | |
|
Börse Stuttgart
| CJH | Delayed | |
|
Boerse Muenchen
| CJH | Real-time |
| 1 day | -35.87% | ||
| 1 month | -35.87% | ||
| 3 months | +13.46% | ||
| 6 months | -23.58% | ||
| Current year | -37.83% |
| 1 month | 2.95 |  | 3.11 |
| Current year | 2.6 | | 4.67 |
| 1 year | 2.6 | | 6.99 |
| 3 years | 1.86 | | 6.99 |
| 5 years | 1.86 | | 29.88 |
| 10 years | 1.86 | | 59.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dong Xu Qiu
PRN | Corporate Officer/Principal | 66 | 2024-02-20 |
Hui Hua Mao
PRN | Corporate Officer/Principal | 64 | 2009-01-12 |
Tao Zhu
CTO | Chief Tech/Sci/R&D Officer | 53 | 2009-01-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Yu
CHM | Chairman | 62 | 2009-01-12 |
Zhong Qi Shao
BRD | Director/Board Member | 63 | 2021-05-27 |
Shou Bai Chao
BRD | Director/Board Member | 63 | 2018-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -35.87% | -.--% | - | - | 2.37B | |
| -2.33% | +0.53% | +51.65% | +115.42% | 1,031B | |
| -1.06% | -1.65% | +42.78% | +69.98% | 638B | |
| -0.65% | -1.32% | +12.98% | +75.49% | 462B | |
| -2.66% | -1.87% | +73.13% | +41.15% | 359B | |
| -1.09% | -5.04% | +22.25% | +39.13% | 335B | |
| -1.51% | -0.32% | +14.00% | +27.00% | 273B | |
| -1.95% | -2.56% | -2.85% | +10.34% | 253B | |
| -0.50% | +3.80% | +49.37% | +56.84% | 228B | |
| -1.47% | -1.53% | +34.28% | +98.89% | 185B | |
| Average | -4.61% | -0.36% | +33.06% | +59.36% | 418.21B | |
| Weighted average by Cap. | -1.24% | -0.35% | +37.44% | +71.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.44B 215M 189M 179M 162M 305M 20.59B 309M 2.14B 825M 10.53B 806M 789M 33.74B | 1.81B 270M 238M 225M 203M 384M 25.9B 388M 2.7B 1.04B 13.24B 1.01B 992M 42.46B |
| Net income | 107M 15.95M 14.05M 13.31M 12.02M 22.65M 1.53B 22.94M 159M 61.28M 782M 59.9M 58.59M 2.51B | 322M 48.04M 42.3M 40.08M 36.18M 68.2M 4.61B 69.08M 480M 185M 2.35B 180M 176M 7.55B |
| Net Debt | 24.02M 3.58M 3.15M 2.99M 2.7M 5.08M 343M 5.15M 35.75M 13.76M 176M 13.45M 13.15M 563M | 415M 61.88M 54.49M 51.63M 46.61M 87.85M 5.93B 88.99M 618M 238M 3.03B 232M 227M 9.72B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6185 Stock
- CASBF Stock
Select your edition
All financial news and data tailored to specific country editions
